loading

Champions Oncology Inc Azioni (CSBR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
27.49%
12.36
17.04 13.49 14.06 14.00
Cost Of Revenue
9.88%
7.271
6.617 7.428 7.072 7.25
Gross Profit
51.22%
5.084
10.42 6.061 6.989 6.752
Operating Expenses
19.72%
7.091
5.923 5.329 5.66 7.023
Benefits Costs and Expenses
14.36%
14.32
12.52 12.75 12.73 14.19
Costs And Expenses
14.36%
14.32
12.52 12.75 12.73 14.19
Depreciation and Amortization
1.01%
0.394
0.398 0.399 0.449 0.457
Operating Income/Loss
144.61%
-2.007
4.499 0.732 1.329 -0.271
Income/Loss From Continuing Operations Before Tax
143.47%
-1.964
4.518 0.739 1.334 -0.19
Income Tax Expense/Benefit
660.87%
-0.129
0.023 0.011 0.021 -0.081
Income/Loss From Continuing Operations After Tax
140.82%
-1.835
4.495 0.728 1.313 -0.109
Net Income/Loss
140.82%
-1.835
4.495 0.728 1.313 -0.109
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.71%
0.0391
13.70 13.59 13.59 0.00912
Diluted Average Shares
99.07%
0.1341
14.36 14.02 14.04 0.00912
Basic Earnings Per Share
142.42%
-0.14
0.33 0.05 0.10 -0.01
Diluted Earnings Per Share
141.94%
-0.13
0.31 0.05 0.09 -0.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):